World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5655)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

149

HTML

3456

Figures (1-2)

475

Tables (1-3)

550

Sum=4630

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

129

Download

687

Sum=816

Oct 15, 2024 (publication date) through Dec 9, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Zhu JJ, Wilding JPH, Gu XS. Combining GLP-1 receptor agonists and SGLT-2 inhibitors for cardiovascular disease prevention in type 2 diabetes: A systematic review with multiple network meta-regressions. World J Diabetes 2024; 15(10): 2135-2146 [PMID: 39493569 DOI: 10.4239/wjd.v15.i10.2135]
URL:	https://www.wjgnet.com/1948-9358/full/v15/i10/2135.htm

Number	Citing Articles
1	Ansari Sajjad Husain Mumtaz Ahmad, Sunita S. Deore. Development and Validation of HPLC Method for Metformin and Canagliflozin in Bulk and Pharmaceutical Dosage Form Using the QbD Approach. Drug Metabolism and Bioanalysis Letters 2025; 18(2): 180 doi: 10.2174/0118723128365462250312061951
2	Gökhan Koker, Muhammed Ali Coskuner. Comment on “SGLT2i–GLP-1RA combination and cardiovascular outcomes in T2D with ACS”. International Journal of Cardiology 2025; 441: 133700 doi: 10.1016/j.ijcard.2025.133700
3	Vanishri Ganakumar, Cornelius J Fernandez, Joseph M Pappachan. Antidiabetic combination therapy and cardiovascular outcomes: An evidence-based approach. World Journal of Diabetes 2025; 16(4): 102390 doi: 10.4239/wjd.v16.i4.102390 Abstract(436) \| Core Tip(436) \| Full Article(HTML)(1679) \| Full Article with Cover (PDF)-2222K(215) \| Audio-569K(13) \| Peer-Review Report-303K(74) \| Answering Reviewers-103K(65) \| Full Article (PDF)-1976K(130) \| Full Article (XML)-160K(75) \| Times Cited (2) \| Total Visits (5198) \| Open
4	Juan J. Gorgojo-Martínez. Adipocentric Strategy for the Treatment of Type 2 Diabetes Mellitus. Journal of Clinical Medicine 2025; 14(3): 678 doi: 10.3390/jcm14030678
5	Jheng-Yan Wu, Wan-Hsuan Hsu, Chia-Chih Kuo, Ya-Wen Tsai, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Kuo-Chuan Hung, Tsung Yu, Chih-Cheng Lai. A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-62891-8